WTAP (Wilms tumor 1-associated protein) is a regulatory component of the m6A RNA methylation machinery that plays crucial roles in RNA processing and disease pathogenesis. As part of the m6A methyltransferase complex, WTAP associates with METTL3 and METTL14 to catalyze N6-methyladenosine modifications on RNAs 12. WTAP is essential for proper localization of the methyltransferase complex to nuclear speckles and is required for catalytic activity in vivo 2. The protein facilitates recruitment of the m6A methyltransferase complex to mRNA targets and regulates alternative splicing of genes involved in transcription and RNA processing 2. In disease contexts, WTAP shows significant clinical relevance. It is highly expressed in hepatocellular carcinoma where it promotes tumor progression through m6A-mediated epigenetic silencing of tumor suppressor ETS1 via the HuR pathway 3. Additionally, WTAP contributes to hyperinflammatory responses by undergoing p65-dependent transcriptional upregulation and facilitating phase separation to enhance m6A modification of inflammatory transcripts 4. WTAP also participates in immunosuppression through the circCCAR1/miR-127-5p/WTAP feedback loop that promotes CD8+ T-cell dysfunction and anti-PD1 therapy resistance in hepatocellular carcinoma 5. These findings establish WTAP as both a critical RNA processing regulator and potential therapeutic target.